$2.15
11.52% yesterday
Nasdaq, Sep 22, 10:15 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock price

$2.15
+1.04 93.69% 1M
-0.27 11.16% 6M
-1.56 42.05% YTD
-1.24 36.58% 1Y
-7.61 77.97% 3Y
-66.59 96.87% 5Y
-11.22 83.92% 10Y
-11.22 83.92% 20Y
Nasdaq, Closing price Mon, Sep 22 2025
-0.28 11.52%
ISIN
US14161W1053
Symbol
CDLX
Industry

Key metrics

Basic
Market capitalization
$114.5m
Enterprise Value
$282.0m
Net debt
$167.6m
Cash
$46.8m
Shares outstanding
51.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.4 | 0.5
EV/Sales
1.1 | 1.2
EV/FCF
negative
P/B
2.0
Financial Health
Equity Ratio
17.8%
Return on Equity
-270.5%
ROCE
-24.7%
ROIC
-
Debt/Equity
3.7
Financials (TTM | estimate)
Revenue
$266.2m | $243.6m
EBITDA
$-31.8m | $-750.0k
EBIT
$-57.3m | $-27.1m
Net Income
$-183.3m | $-19.9m
Free Cash Flow
$-19.6m
Growth (TTM | estimate)
Revenue
-12.8% | -12.5%
EBITDA
46.6% | 98.0%
EBIT
32.7% | 57.5%
Net Income
-19.6% | 89.5%
Free Cash Flow
23.3%
Margin (TTM | estimate)
Gross
54.7%
EBITDA
-12.0% | -0.3%
EBIT
-21.5%
Net
-68.9% | -8.2%
Free Cash Flow
-7.4%
More
EPS
$-3.5
FCF per Share
$-0.4
Short interest
16.6%
Employees
454
Rev per Employee
$610.0k
Show more

Is Cardlytics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Cardlytics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Cardlytics, Inc. forecast:

6x Hold
60%
4x Sell
40%

Analyst Opinions

10 Analysts have issued a Cardlytics, Inc. forecast:

Hold
60%
Sell
40%

Financial data from Cardlytics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
266 266
13% 13%
100%
- Direct Costs 121 121
15% 15%
45%
146 146
11% 11%
55%
- Selling and Administrative Expenses 131 131
11% 11%
49%
- Research and Development Expense 46 46
10% 10%
17%
-32 -32
47% 47%
-12%
- Depreciation and Amortization 25 25
0% 0%
10%
EBIT (Operating Income) EBIT -57 -57
33% 33%
-22%
Net Profit -183 -183
20% 20%
-69%

In millions USD.

Don't miss a Thing! We will send you all news about Cardlytics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardlytics, Inc. Stock News

Neutral
Business Wire
8 days ago
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the full and timely repayment of the remaining $46.1 million aggregate principal amount of its 1.00% convertible senior notes due on September 15, 2025. Following this repayment, Cardlytics now has $172.5 million aggregate principal amount outstanding of its 4.25% convertible senior notes due in 2029 and $50 million drawn ...
Neutral
Business Wire
about one month ago
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced that Cardlytics' card-linked offer (CLO) network has won “Best Digital Ad Network” in the 2025 MarTech Breakthrough Awards program conducted by MarTech Breakthrough, a market intelligence organization that recognizes today's most innovative products, solutions, services and companies in the global field of Marketing, Sales...
Neutral
The Motley Fool
about 2 months ago
Cardlytics (CDLX) Q2 Users Jump 19%
More Cardlytics, Inc. News

Company Profile

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Head office United States
CEO Amit Gupta
Employees 454
Founded 2008
Website www.cardlytics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today